Andy brings to Locust Walk experience across the life sciences industry, including an extensive legal background working with emerging growth companies and venture capital funds.  While with Locust Walk, he has worked on buy-side, sell-side, capital markets, IPO advisory, and consulting services engagements for numerous life sciences clients. 

Prior to joining Locust Walk, Andy was an associate at Gunderson Dettmer, one of the nation’s leading business law firms for entrepreneurs, emerging growth companies and venture capitalists.  Andy’s legal practice encompassed all areas of general corporate and securities law, with extensive experience in corporate financings, including public offerings and private placements of equity and debt, and mergers and acquisitions.  Andy also represented life sciences companies in all stages of their life cycles, from start-ups to public companies.  Andy was also previously an associate in the Corporate and Financial Services group at Willkie Farr & Gallagher and in the Healthcare Investment Banking group at Credit Suisse. 

Andy holds an MBA from New York University Stern School of Business, a JD from New York University School of Law and a BSE in Biomedical and Electrical Engineering from Duke University.  He is licensed to practice law in Massachusetts and New York. 

He is a FINRA registered representative and holds his Series 79 and 63 licenses.